United States Neurological Biomarker Market Report 2016

October 2016 | 121 pages | ID: U8695711B76EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Neurological Biomarker

Revenue, means the sales value of Neurological Biomarker

This report studies sales (consumption) of Neurological Biomarker in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Myriad RBM
• Proteome Sciences
• QIAGEN
• Thermo Fisher Scientific
• AbaStar MDx
• Abiant
• Acumen Pharmaceuticals
• Aepodia
• Alseres Pharmaceuticals
• Athena Diagnostics
• Banyan Biomarkers
• Cisbio Bioassays
• Diagenic
• Proteosys
• Psynova Neurotech

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Neurological Biomarker in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Neurological Biomarker Market Report 2016

1 NEUROLOGICAL BIOMARKER OVERVIEW

1.1 Product Overview and Scope of Neurological Biomarker
1.2 Classification of Neurological Biomarker
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Neurological Biomarker
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Neurological Biomarker (2011-2021)
  1.4.1 United States Neurological Biomarker Sales and Growth Rate (2011-2021)
  1.4.2 United States Neurological Biomarker Revenue and Growth Rate (2011-2021)

2 UNITED STATES NEUROLOGICAL BIOMARKER COMPETITION BY MANUFACTURERS

2.1 United States Neurological Biomarker Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Neurological Biomarker Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Neurological Biomarker Average Price by Manufactures (2015 and 2016)
2.4 Neurological Biomarker Market Competitive Situation and Trends
  2.4.1 Neurological Biomarker Market Concentration Rate
  2.4.2 Neurological Biomarker Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NEUROLOGICAL BIOMARKER SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Neurological Biomarker Sales and Market Share by Type (2011-2016)
3.2 United States Neurological Biomarker Revenue and Market Share by Type (2011-2016)
3.3 United States Neurological Biomarker Price by Type (2011-2016)
3.4 United States Neurological Biomarker Sales Growth Rate by Type (2011-2016)

4 UNITED STATES NEUROLOGICAL BIOMARKER SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Neurological Biomarker Sales and Market Share by Application (2011-2016)
4.2 United States Neurological Biomarker Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES NEUROLOGICAL BIOMARKER MANUFACTURERS PROFILES/ANALYSIS

5.1 Myriad RBM
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Neurological Biomarker Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Myriad RBM Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Proteome Sciences
  5.2.2 Neurological Biomarker Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Proteome Sciences Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 QIAGEN
  5.3.2 Neurological Biomarker Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 QIAGEN Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Thermo Fisher Scientific
  5.4.2 Neurological Biomarker Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Thermo Fisher Scientific Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 AbaStar MDx
  5.5.2 Neurological Biomarker Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 AbaStar MDx Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abiant
  5.6.2 Neurological Biomarker Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abiant Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Acumen Pharmaceuticals
  5.7.2 Neurological Biomarker Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Acumen Pharmaceuticals Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Aepodia
  5.8.2 Neurological Biomarker Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Aepodia Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Alseres Pharmaceuticals
  5.9.2 Neurological Biomarker Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Alseres Pharmaceuticals Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Athena Diagnostics
  5.10.2 Neurological Biomarker Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Athena Diagnostics Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Banyan Biomarkers
5.12 Cisbio Bioassays
5.13 Diagenic
5.14 Proteosys
5.15 Psynova Neurotech

6 NEUROLOGICAL BIOMARKER MANUFACTURING COST ANALYSIS

6.1 Neurological Biomarker Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Neurological Biomarker

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Neurological Biomarker Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Neurological Biomarker Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES NEUROLOGICAL BIOMARKER MARKET FORECAST (2016-2021)

10.1 United States Neurological Biomarker Sales, Revenue Forecast (2016-2021)
10.2 United States Neurological Biomarker Sales Forecast by Type (2016-2021)
10.3 United States Neurological Biomarker Sales Forecast by Application (2016-2021)
10.4 Neurological Biomarker Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neurological Biomarker
Table Classification of Neurological Biomarker
Figure United States Sales Market Share of Neurological Biomarker by Type in 2015
Table Application of Neurological Biomarker
Figure United States Sales Market Share of Neurological Biomarker by Application in 2015
Figure United States Neurological Biomarker Sales and Growth Rate (2011-2021)
Figure United States Neurological Biomarker Revenue and Growth Rate (2011-2021)
Table United States Neurological Biomarker Sales of Key Manufacturers (2015 and 2016)
Table United States Neurological Biomarker Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Neurological Biomarker Sales Share by Manufacturers
Figure 2016 Neurological Biomarker Sales Share by Manufacturers
Table United States Neurological Biomarker Revenue by Manufacturers (2015 and 2016)
Table United States Neurological Biomarker Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Neurological Biomarker Revenue Share by Manufacturers
Table 2016 United States Neurological Biomarker Revenue Share by Manufacturers
Table United States Market Neurological Biomarker Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Neurological Biomarker Average Price of Key Manufacturers in 2015
Figure Neurological Biomarker Market Share of Top 3 Manufacturers
Figure Neurological Biomarker Market Share of Top 5 Manufacturers
Table United States Neurological Biomarker Sales by Type (2011-2016)
Table United States Neurological Biomarker Sales Share by Type (2011-2016)
Figure United States Neurological Biomarker Sales Market Share by Type in 2015
Table United States Neurological Biomarker Revenue and Market Share by Type (2011-2016)
Table United States Neurological Biomarker Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Neurological Biomarker by Type (2011-2016)
Table United States Neurological Biomarker Price by Type (2011-2016)
Figure United States Neurological Biomarker Sales Growth Rate by Type (2011-2016)
Table United States Neurological Biomarker Sales by Application (2011-2016)
Table United States Neurological Biomarker Sales Market Share by Application (2011-2016)
Figure United States Neurological Biomarker Sales Market Share by Application in 2015
Table United States Neurological Biomarker Sales Growth Rate by Application (2011-2016)
Figure United States Neurological Biomarker Sales Growth Rate by Application (2011-2016)
Table Myriad RBM Basic Information List
Table Myriad RBM Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Myriad RBM Neurological Biomarker Sales Market Share (2011-2016)
Table Proteome Sciences Basic Information List
Table Proteome Sciences Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table Proteome Sciences Neurological Biomarker Sales Market Share (2011-2016)
Table QIAGEN Basic Information List
Table QIAGEN Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table QIAGEN Neurological Biomarker Sales Market Share (2011-2016)
Table Thermo Fisher Scientific Basic Information List
Table Thermo Fisher Scientific Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table Thermo Fisher Scientific Neurological Biomarker Sales Market Share (2011-2016)
Table AbaStar MDx Basic Information List
Table AbaStar MDx Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbaStar MDx Neurological Biomarker Sales Market Share (2011-2016)
Table Abiant Basic Information List
Table Abiant Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abiant Neurological Biomarker Sales Market Share (2011-2016)
Table Acumen Pharmaceuticals Basic Information List
Table Acumen Pharmaceuticals Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table Acumen Pharmaceuticals Neurological Biomarker Sales Market Share (2011-2016)
Table Aepodia Basic Information List
Table Aepodia Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aepodia Neurological Biomarker Sales Market Share (2011-2016)
Table Alseres Pharmaceuticals Basic Information List
Table Alseres Pharmaceuticals Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alseres Pharmaceuticals Neurological Biomarker Sales Market Share (2011-2016)
Table Athena Diagnostics Basic Information List
Table Athena Diagnostics Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table Athena Diagnostics Neurological Biomarker Sales Market Share (2011-2016)
Table Banyan Biomarkers Basic Information List
Table Banyan Biomarkers Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table Banyan Biomarkers Neurological Biomarker Sales Market Share (2011-2016)
Table Cisbio Bioassays Basic Information List
Table Cisbio Bioassays Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cisbio Bioassays Neurological Biomarker Sales Market Share (2011-2016)
Table Diagenic Basic Information List
Table Diagenic Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table Diagenic Neurological Biomarker Sales Market Share (2011-2016)
Table Proteosys Basic Information List
Table Proteosys Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table Proteosys Neurological Biomarker Sales Market Share (2011-2016)
Table Psynova Neurotech Basic Information List
Table Psynova Neurotech Neurological Biomarker Sales, Revenue, Price and Gross Margin (2011-2016)
Table Psynova Neurotech Neurological Biomarker Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Biomarker
Figure Manufacturing Process Analysis of Neurological Biomarker
Figure Neurological Biomarker Industrial Chain Analysis
Table Raw Materials Sources of Neurological Biomarker Major Manufacturers in 2015
Table Major Buyers of Neurological Biomarker
Table Distributors/Traders List
Figure United States Neurological Biomarker Production and Growth Rate Forecast (2016-2021)
Figure United States Neurological Biomarker Revenue and Growth Rate Forecast (2016-2021)
Table United States Neurological Biomarker Production Forecast by Type (2016-2021)
Table United States Neurological Biomarker Consumption Forecast by Application (2016-2021)